92 results match your criteria perforating folliculitis


Acquired Reactive Perforating Collagenosis: A Case Report.

Cureus 2021 Feb 27;13(2):e13583. Epub 2021 Feb 27.

Dermatology, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences, Casablanca, MAR.

Reactive perforating collagenosis (RPC) is a rare form of dermatosis. It forms with perforating folliculitis, Kyrle's disease, and serpiginous perforating elastosis, which is a group of perforating dermatosis. RPC can be hereditary with autosomal dominant transmission or it can be acquired, which is usually observed in diabetics with chronic renal failure. Read More

View Article and Full-Text PDF
February 2021

Evaluation of clinicopathological and treatment characteristics of 80 patients with acquired perforating dermatosis.

Dermatol Ther 2020 11 5;33(6):e14465. Epub 2020 Nov 5.

Department of Pathology, University of Health Science (HSU) Istanbul Training and Research Hospital, Istanbul, Turkey.

Acquired perforating dermatosis (APD) is a group of a rare dermatological disorder characterized by elimination of dermal connective tissue through epidermis. We aimed to evaluate the characteristics of patients diagnosed with APD and to determine the differences in comorbidities according to subtypes of APD. A retrospective, observational, cross-sectional study was designed. Read More

View Article and Full-Text PDF
November 2020

Clinical practice guide for the treatment of perforating dermatosis.

J Dermatol 2020 Dec 23;47(12):1374-1382. Epub 2020 Oct 23.

Department of Dermatology, Juntendo University Urayasu Hospital, Urayasu, Japan.

Perforating dermatoses are a heterogeneous skin disease group defined by transepidermal elimination of various skin materials. Four classical forms of primary perforating dermatosis have been described, where the transepidermal elimination mechanism represents the hallmark of the disease: acquired reactive perforating collagenosis, elastosis perforans serpiginosa, Kyrle's disease and perforating folliculitis. Acquired reactive perforating collagenosis presents with transepidermal elimination of collagen fibers. Read More

View Article and Full-Text PDF
December 2020

Dasatinib-Induced Perforating Folliculitis in a Bone Marrow Transplant Patient.

Indian Dermatol Online J 2020 Jul-Aug;11(4):635-638. Epub 2020 Jul 13.

Department of Pathology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.

View Article and Full-Text PDF

Perforating folliculitis triggered by bevacizumab administration.

J Dermatol 2020 Aug 28;47(8):e298-e299. Epub 2020 May 28.

Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

View Article and Full-Text PDF

A Case of Perforating Folliculitis Induced by Vemurafenib.

Acta Derm Venereol 2019 Feb;99(2):230-231

Department of Dermatology , Ehime University Graduate School of Medicine, 791-0295 Toon, Japan.

View Article and Full-Text PDF
February 2019

Diffuse pruritic papules.

JAAD Case Rep 2018 Sep 12;4(8):749-751. Epub 2018 Sep 12.

Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.

View Article and Full-Text PDF
September 2018

Perforating folliculitis in association with liver impairment in a patient with chronic ductopenic rejection of liver transplant.

Clin Exp Dermatol 2019 03 19;44(2):210-212. Epub 2018 May 19.

Department of Dermatology, Saint Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK.

View Article and Full-Text PDF

Nilotinib-induced Perforating Folliculitis: Two Cases.

Int J Trichology 2018 Mar-Apr;10(2):89-91

Department of Dermatology, Jorhat Medical College and Hospital, Jorhat, Assam, India.

Cutaneous adverse effects of chemotherapy are widely known but underreported. A significant advancement is made in the field of oncology with the advent of new classes of drug being added to the existing classes at a fast pace. Most of these cutaneous adverse effects are self-limiting and subsides on suspending the drug either temporarily or permanently. Read More

View Article and Full-Text PDF

Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study.

Indian Dermatol Online J 2018 Jan-Feb;9(1):20-26

Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra, Himachal Pradesh, India.

Background: Chronic kidney disease (CKD)-associated mucocutaneous manifestations significantly impair the quality of life but often remain understudied. They may also vary across regions, socioeconomic and nutritional status, and racial differences.

Objectives: To study the patterns of mucocutaneous disorders and their prevalence in CKD patients irrespective of clinical stage or dialysis status. Read More

View Article and Full-Text PDF
February 2018

Perforating Folliculitis Secondary to Bendamustine-Rituximab Chemotherapy: A Case Report.

Indian Dermatol Online J 2017 Jul-Aug;8(4):290-292

Department of Dermatology and Pathology, St. Johns Medical College, Bengaluru, Karnataka, India.

View Article and Full-Text PDF

Acquired perforating dermatosis in a patient with chronic renal failure.

An Bras Dermatol 2016 Sep-Oct;91(5 suppl 1):10-13

Universidade Federal do Estado do Rio de Janeiro (UNIRIO) - Rio de Janeiro (RJ), Brazil.

Perforating dermatoses are a group of skin diseases characterized by transepidermal elimination of dermal material. The disease is divided into two groups: the primary group and the secondary group. The classical or primary perforating dermatoses are subdivided into four types according to the eliminated dermal materials: Kyrle disease, perforating reactive collagenosis, elastosis perforans serpiginosa, and perforating folliculitis. Read More

View Article and Full-Text PDF

Dermoscopy in General Dermatology: A Practical Overview.

Dermatol Ther (Heidelb) 2016 Dec 9;6(4):471-507. Epub 2016 Sep 9.

Department of Experimental and Clinical Medicine, Institute of Dermatology, University of Udine, Udine, Italy.

Over the last few years, dermoscopy has been shown to be a useful tool in assisting the noninvasive diagnosis of various general dermatological disorders. In this article, we sought to provide an up-to-date practical overview on the use of dermoscopy in general dermatology by analysing the dermoscopic differential diagnosis of relatively common dermatological disorders grouped according to their clinical presentation, i.e. Read More

View Article and Full-Text PDF
December 2016

The practical usefulness of dermoscopy in general dermatology.

G Ital Dermatol Venereol 2015 Oct 18;150(5):533-46. Epub 2015 Jun 18.

Department of Experimental and Clinical Medicine Institute of Dermatology University of Udine, Udine, Italy -

Beside to traditional use, dermoscopy is more and more used in the assessment of other "general" dermatologic conditions, namely scalp and hair disorders (trichoscopy), nails abnormalities (onychoscopy), skin infections and infestations (entomodermoscopy), and cutaneous inflammatory diseases (inflammoscopy). Among the list of new applications of dermoscopy, the study of inflammatory dermatoses is probably the most promising topic in terms of development and usefulness, considering the large number of such disorders and the frequent problems in their differential diagnosis which the dermatologist encounters in own daily clinical practice. In this paper, we report selected relatively common clinical differential diagnosis issues concerning inflammatory dermatoses (and some clinically related noninflammatory conditions), analysing them by a dermoscopic point of view in order to assist their noninvasive resolution according to the available literature data and our personal experience, including papulosquamous dermatoses (guttate psoriasis, pityriasis lichenoides chronica, pityriasis rosea, lichen planus, lymphomatoid papulosis, classic pityriasis rubra pilaris, papulosquamous sarcoidosis, disseminated forms of porokeratosis and papulosquamous chronic GVHD), dermatoses presenting with erythematous-desquamative patches/plaques (plaque psoriasis, eczematous dermatitis, pityriasis rosea, mycosis fungoides, subacute cutaneous lupus erythematosus), palmar psoriasis vs. Read More

View Article and Full-Text PDF
October 2015

A case of perforating folliculitis in association with antisynthetase syndrome.

J Biol Regul Homeost Agents 2015 Jan-Mar;29(1 Suppl):95-8

”Onkoderma”-Clinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria.

Perforating folliculitis (PF) describes the process by which altered dermal material is eliminated from the epidermis through a follicular unit resulting in keratotic, follicular papules that favor hair-bearing regions of the forearms, arms, buttocks, and thighs. Diabetes mellitus (DM) and chronic renal failure (CRF) are commonly associated with PF. The more general term, acquired perforating dermatosis, has been applied to PF as well as Kyrle’s disease and the non-inherited form of perforating collagenosis. Read More

View Article and Full-Text PDF

Late onset perforating folliculitis induced by lenalidomide: a case report.

Br J Dermatol 2015 Aug 19;173(2):618-20. Epub 2015 Jun 19.

Department of Dermatology, Reference Centre for Cutaneous Adverse Drug Reactions, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

View Article and Full-Text PDF

Delayed onset perforating folliculitis associated with sorafenib.

Australas J Dermatol 2014 Aug;55(3):233-5

Department of Dermatology, Hospital Álvarez-Buylla, Mieres, Spain.

View Article and Full-Text PDF

A clinicopathologic study of thirty cases of acquired perforating dermatosis in Korea.

Ann Dermatol 2014 Apr 30;26(2):162-71. Epub 2014 Apr 30.

Department of Dermatology, Eulji General Hospital, Eulji University, Seoul, Korea.

Background: Acquired perforating dermatosis (APD) is histopathologically characterized by transepidermal elimination of materials from the upper dermis. APD can be divided into four diseases: Kyrle's disease, perforating folliculitis, elastosis perforans serpiginosa, and reactive perforating collagenosis. APD is usually associated with systemic diseases, especially diabetes mellitus or chronic renal failure. Read More

View Article and Full-Text PDF

Clinicopathological features of 25 patients with acquired perforating dermatosis.

Eur J Dermatol 2013 Nov-Dec;23(6):864-71

Dermatology Clinic.

Background: Acquired perforating dermatosis (APD) is a rare group of skin disorders characterized by transepidermal elimination of dermal tissue material. There are only a few studies of APD.

Objective: We aimed to review the clinicopathologic features of patients with APD and evaluate the outcomes of treatments. Read More

View Article and Full-Text PDF
February 2015

Perforating disorders of the skin.

Indian J Pathol Microbiol 2013 Oct-Dec;56(4):355-8

Department of pathology, K. J. Somaiya Medical College and Research Centre, Mumbai, Maharashtra, India.

Background: Perforating disorders of the skin, is an often overlooked entity characterized by transepidermal elimination of material from the upper dermis and are classified histopathologically according to the type of epidermal disruption and the nature of the eliminated material. They include Kyrle's disease, perforating folliculitis, reactive perforating collagenosis, and elastosis perforans serpiginosa.

Aim: The aim of this study was to delineate the clinical and histopathological features of perforating disorders of the skin. Read More

View Article and Full-Text PDF

Follicular psoriasis.

J Cutan Pathol 2013 Oct;40(10):859-62

Department of Pathology, University of Michigan, Ann Arbor, MI, USA.

View Article and Full-Text PDF
October 2013

Acquired perforating dermatosis: a clinical and dermatoscopic correlation.

Dermatol Online J 2013 Jul 14;19(7):18958. Epub 2013 Jul 14.

Center for Clinical Studies, 1401 Binz St., Houston, TX 77004, USA.

Acquired Perforating Dermatosis (APD) is a perforating disease characterized by transepidermal elimination of dermal material [1,2]. This disease usually develops in adulthood. APD has been reported to occur in association with various diseases, but is most commonly associated with dialysis-dependent chronic renal failure (CRF) or diabetes mellitus (DM) [1,2,3,4]. Read More

View Article and Full-Text PDF

Perforating folliculitis in a patient treated with nilotinib: a further evidence of C-kit involvement.

Am J Dermatopathol 2014 Jul;36(7):592-3

*Contrato Río Hortega del ISCIII, Fundación de Investigación De La Princesa, Madrid, Spain; Departments of †Hematology, ‡Dermatology, §Pathology, Hospital Universitario de La Princesa, Madrid, Spain; ‖Department of Dermatology, Fundación Jimenez Diaz, Madrid, Spain.

We present a case of perforating folliculitis in a patient treated with nilotinib, a kinase inhibitor. A 48-year-old man presented with a severely pruritic follicular rash for several months that started after reaching a complete molecular response of his myeloid chronic while treated with nilotinib. Clinical examination showed predominantly follicular pinpoint papules on trunk and proximal extremities and a biopsy showed a slightly dilated hair follicle with a focal disruption of the infundibular follicular epithelium. Read More

View Article and Full-Text PDF

Necrotizing infundibular crystalline folliculitis manifesting as a perforating mucinosis: a case report.

Am J Dermatopathol 2013 Oct;35(7):757-60

*Department of Pathology and Laboratory Medicine, and †Division of Dermatology, University of Kansas Medical Center, Kansas City, KS ‡Department of Pathology, SUNY Upstate Medical University, Syracuse, NY.

: Necrotizing infundibular crystalline folliculitis (NICF) is a rare entity manifesting as waxy folliculocentric papules comprised of filamentous birefringent crystalline deposits. We report a case of NICF in an 85-year-old man, presenting as gritty, cream-colored, and erythematous papules across the midline back. Biopsy demonstrated a pale plug comprised of copious mucin. Read More

View Article and Full-Text PDF
October 2013

[Reactive perforating collagenosis].

Ann Dermatol Venereol 2012 Jun 30;139(6-7):481-5. Epub 2012 May 30.

Service de dermatologie, hôpital central de l'Armée Ain Naadja (HCA), Kouba 16000 Alger, Algérie. salhi

Background: Reactive perforating collagenosis (RPC) belongs to the group of perforating dermatoses, which comprises elastosis perforans serpiginosa, RPC, perforating folliculitis and Kyrle's disease. RPC was initially described as a distinctive form of transepithelial elimination of altered collagen related to superficial trauma. Two types are distinguished: a hereditary type (MIM 216700), which is rare and begins during early childhood, and a second type, called acquired RPC, which is more frequent, appears in adults and is associated with other diseases, diabetes mellitus, renal insufficiency, solid tumors, lymphomas and AIDS. Read More

View Article and Full-Text PDF